DarioHealth Corp. (NASDAQ:DRIO) Q3 2021 Earnings Conference Call November 16, 2021 8:30 AM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen and Compay David Grossman - Stifel Nathan Weinstein - Aegis Capital Ben Haynor - Alliance Global Partners Operator Greetings and we ...

Table of Contents ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |-------------------------------------------------------------------------------------------------|-----------------------| | (Exact name of registrant as specified in its charter) \nDe ...

DarioHealth Corp. (NASDAQ:DRIO) Q2 2021 Earnings Conference Call August 16, 2021 8:30 AM ET Company Participants Chuck Padala - Investor Relations Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen David Grossman - Stifel Ben Haynor - Alliance Global Partners Operator Greetings and welcome to the DarioHealth Corporation’s Second Q ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 | --- | --- | |------------------------------------------------------------------------------------------------ ...

DarioHealth Corp. (NASDAQ:DRIO) Q1 2021 Earnings Conference Call May 18, 2021 8:30 AM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President and General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Charles Rhyee - Cowen David Grossman - Stifel Joe Downing - Cantor Fitzgerald Nathan Weinstein - Aegis Capital Operator Greetings and welcome to the DarioHeal ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. (Exact name of registrant as specified in its charter) Delaware 45-2973162 (State or other j ...

DarioHealth Corp. (NASDAQ:DRIO) Q4 2020 Earnings Conference Call March 9, 2021 8:30 AM ET Company Participants Glenn Garmont - Managing Director, Life Sci Advisors Erez Raphael - President and Chief Executive Officer Zvi Ben-David - Chief Financial Officer Rick Anderson - President, General Manager, North America Conference Call Participants Alex Nowak - Craig-Hallum Charles Rhyee - Cowen and Company Steve Halper - Cantor Fitzgerald David Grossman - Stifel Nathan Weinstein - Aegis Capital Operator Greetings ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered: Common Stock, par value $0.0001 per share DRIO The Nasdaq Stock Market LLC Warrants to purchase Common Stock DRIOW The Nasdaq Stock Market LLC FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES ...

DarioHealth Corp. (NASDAQ:DRIO) Q3 2020 Earnings Conference Call November 12, 2020 9:00 AM ET Company Participants Glenn Garmont - IR Erez Raphael - President and CEO Zvi Ben-David - CFO Rick Anderson - President, General Manager, North America Conference Call Participants Scott Schoenhaus - Stephens John Vandermosten - Zacks SCR Operator Good day, ladies and gentleman, and welcome to DarioHealth Third Quarter Conference Call. As a reminder, this call is being recorded. At this time, it is my pleasure to tu ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37704 DarioHealth Corp. (Exact name of registrant as specified in its charter) Delaware 45-2973162 (State or other jurisdiction of ...